Jun 25, 2026
15 MIN READ

NAD+ vs Zepbound — What Actually Works for Weight Loss

NAD+ supplements and prescription weight loss drugs like Zepbound work through completely different biological pathways. Understanding the science behind each can help you choose the right approach for your weight loss goals.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 25, 2026
15 MIN READ

nad+ vs zepbound — what actually works for weight loss — PlexusDx GLP-1 education

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The weight loss market now offers two distinct strategies: cellular energy supplements like NAD+ and FDA-approved medications such as Zepbound (tirzepatide). NAD+ focuses on mitochondrial function and cellular metabolism, while GLP-1 and GIP receptor agonists like Zepbound directly regulate appetite and glucose control. PlexusDx offers a personalized approach to weight loss medications that targets your unique genetic profile rather than one-size-fits-all solutions.

How NAD+ Claims to Support Weight Loss

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell that plays a role in energy metabolism and mitochondrial function. Supplement companies market NAD+ precursors—such as NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide)—as anti-aging and metabolism-boosting tools. The theory is that higher NAD+ levels improve cellular energy production, potentially increasing calorie burn and reducing fatigue during weight loss efforts.

However, clinical evidence for NAD+ supplementation and weight loss remains limited in humans. Most studies showing NAD+ benefits were conducted in laboratory settings or animal models, not in controlled human trials. Oral NAD+ supplements have poor bioavailability, meaning your digestive system breaks down much of the compound before it reaches your bloodstream. While NAD+ may support overall cellular health and energy, it does not directly suppress appetite or regulate the hormonal pathways that drive weight gain.

Zepbound and Tirzepatide: The Science Behind GIP-GLP-1 Agonism

Zepbound (tirzepatide) is an FDA-approved medication that activates two separate appetite-control pathways: GLP-1 and GIP receptors. Clinical trials showed that tirzepatide produced sustained weight loss of 20–22% of body weight over 68 weeks in people without diabetes. Unlike NAD+ supplements, tirzepatide directly tells your brain to eat less, slows stomach emptying to increase fullness, and improves blood sugar control—all mechanisms proven in large-scale human trials.

Tirzepatide works by mimicking natural hormones your body already produces when you eat. GLP-1 suppresses appetite and increases insulin secretion; GIP enhances glucose control and may amplify weight loss effects. This dual-receptor approach addresses multiple biological drivers of obesity simultaneously, which explains why tirzepatide produces far greater weight loss than single-pathway medications or supplements alone.

Clinical Evidence: What the Research Actually Shows

The SURMOUNT trials demonstrated that tirzepatide reduced body weight by an average of 21% compared to 2–3% for placebo over 72 weeks. Participants continued to lose weight even after 2 years of treatment. No comparable large-scale human trial exists for NAD+ supplementation and weight loss, making direct comparison impossible from an evidence standpoint.

NAD+ research has focused on cellular aging, mitochondrial health, and exercise recovery—not weight loss specifically. While maintaining healthy mitochondrial function supports overall metabolism, the effect is indirect and modest compared to medications that actively regulate hunger hormones. If your goal is measurable, sustained weight loss, the clinical evidence strongly favors GLP-1 and GIP receptor agonists like tirzepatide over NAD+ alone.

Why Genetic Variation Matters More Than Supplement Type

Not every person responds equally to the same weight loss medication or supplement. Genetic differences in your GLP1R, GIPR, FTO, and MC4R genes influence how strongly you respond to appetite-suppressing drugs and how your body regulates hunger signals. Someone with a favorable GLP1R variant may see dramatic results from tirzepatide, while another person's genetic makeup may require dose adjustments or a different compound altogether.

PlexusDx offers the Precision Peptide Genetic Test to map your peptide-pathway genes and reveal which weight loss medications will work best for your biology. This test identifies 14 metabolic pathways and 150+ genetic insights—information that no NAD+ supplement can provide. With PlexusDx, your medication and dose are personalized to your genetic profile, not chosen based on generic marketing claims or trial averages.

PlexusDx Tirzepatide: Prescription-Strength Results at Stable Pricing

PlexusDx compounded tirzepatide injection starts at $249 per month and uses only licensed 503A compounding pharmacies—the same quality and sterility standard as brand-name medications. Unlike supplement subscriptions that charge more as you increase dosage, PlexusDx tirzepatide pricing remains flat regardless of your dose tier. Your dose may need to go up. Your price won't.

Tirzepatide from PlexusDx is available in all 50 states without insurance or membership fees, and it qualifies for HSA and FSA accounts. After your first month, you can add the Precision Peptide Genetic Test ($99) to unlock personalized dosing and compound recommendations based on your genetic predispositions. This combination of proven medication, genetic insight, and transparent pricing delivers clinical results that NAD+ supplementation cannot match.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can NAD+ supplements replace prescription weight loss drugs?

No. NAD+ supports cellular energy and mitochondrial function, but it does not directly suppress appetite or regulate hunger hormones the way tirzepatide does. NAD+ may be a useful addition to overall health, but clinical evidence shows GLP-1 and GIP receptor agonists produce far greater and more sustained weight loss when weight loss is the primary goal.

How much weight loss should I expect from tirzepatide?

Clinical trials show average weight loss of 20–22% of body weight over 68 weeks with tirzepatide, though individual results vary based on genetics, lifestyle, and dose. Your personal response depends partly on your GLP1R and GIPR gene variants, which PlexusDx can identify through the Precision Peptide Genetic Test to predict your likely treatment outcome.

Is PlexusDx tirzepatide the same as brand-name Zepbound?

PlexusDx tirzepatide is compounded by licensed 503A pharmacies and contains the same active ingredient as Zepbound, but at a lower cost ($249–$289/mo vs. $1,000+/mo for Zepbound). It's available nationwide without insurance, HSA/FSA eligible, and pricing stays flat regardless of your dose.

Are there side effects with tirzepatide that NAD+ doesn't have?

Tirzepatide may cause nausea, vomiting, or constipation—common GLP-1 class effects that usually improve over time. NAD+ supplements are generally well-tolerated but lack proven weight loss benefits. The question isn't about side effects; it's whether the medication actually achieves your weight loss goal, which tirzepatide does in clinical trials and NAD+ does not.

How does the Precision Peptide Genetic Test help with tirzepatide?

PlexusDx's Precision Peptide Genetic Test ($99 add-on after month one) analyzes your GLP1R, GIPR, FTO, and MC4R variants to reveal your genetic predisposition to tirzepatide response and personalized dosing recommendations. This genetic insight helps optimize your medication choice and dose, increasing your chances of meaningful weight loss compared to a one-size-fits-all approach.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves